The 65th Annual Meeting of the Japan Lung Cancer Society

Presentation information

一般演題(口演)

一般演題(口演)13 周術期治療(EGFR)

Thu. Oct 31, 2024 3:00 PM - 4:00 PM 第10会場 (パシフィコ横浜ノース 4階 G414+G415)

座長:中村 廣繁(松江赤十字病院呼吸器外科), 三浦 理(新潟県立がんセンター新潟病院内科:呼吸器)

[O13-2] MRD analysis from ADAURA trial of adjuvant osimertinib in resected EGFRm stage IB-IIIA NSCLC

Masahiro Tsuboi1, Thomas John2, Christian Grohe3, Jonathan Goldman4, Terufumi Kato5, Konstantin Laktionov6, Laura Bonanno7, Marcello Tiseo8, Margarita Majem9, Manuel Domine10, Myung-Ju Ahn11, Maurice Perol12, Ryan Hartmaier13, Jacqulyne Robichaux13, Preetida Bhetariya14, Aleksandra Markovets14, Yuri Rukazenkov15, Caitlin Muldoon16, Roy S. Herbst17, Yi-Long Wu18 (1.Department of Thoracic Surgery and Oncology, National Cancer Center Hospital East, Kashiwa, Japan, 2.Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia;Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia, 3.Klinik fur Pneumologie-Evangelische Lungenklinik Berlin Buch, Berlin, Germany, 4.David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA, 5.Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan, 6.Federal State Budgetary Institution“N. N. Blokhin National Medical Research Center of Oncology”of the Ministry of Health of the Russian Federation, Moscow, Russia, 7.Medical Oncology 2, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy, 8.Medical Oncology Unit, University Hospital of Parma, Parma, Italy, 9.Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 10.Department of Medical Oncology, Hospital Universitario Fundacion Jimenez Diaz, IIS-FJD, Madrid, Spain, 11.Sungkyunkwan University School of Medicine, Seoul, Republic of Korea, 12.Department of Medical Oncology, Leon-Berard Cancer Center, Lyon, France, 13.Translational Medicine, Oncology Research and Development, AstraZeneca, Boston, USA, 14.Oncology Data Science, Oncology Research and Development, AstraZeneca, Boston, USA, 15.Late-stage Development, Oncology Research and Development, AstraZeneca, Cambridge, UK, 16.Biometrics, Oncology Research and Development, AstraZeneca, Cambridge, UK, 17.Medical Oncology, Yale School of Medicine and Yale Cancer Center, New Haven, CT, USA, 18.Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital(Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China)

アンコール演題

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

Password